[18F]PSMA-1007 PET is comparable to [99mTc]Tc-DMSA SPECT for renal cortical imaging
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
[18F]PSMA-1007 PET is comparable to [99mTc]Tc-DMSA SPECT for renal cortical imaging ; volume:7 ; number:1 ; day:24 ; month:11 ; year:2023 ; pages:1-10 ; date:12.2023
European journal of hybrid imaging ; 7, Heft 1 (24.11.2023), 1-10, 12.2023
- Creator
-
Valind, Kristian
Minarik, David
Garpered, Sabine
Persson, Eva
Jögi, Jonas
Trägårdh, Elin
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s41824-023-00185-2
- URN
-
urn:nbn:de:101:1-2024012211555278789034
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Valind, Kristian
- Minarik, David
- Garpered, Sabine
- Persson, Eva
- Jögi, Jonas
- Trägårdh, Elin
- SpringerLink (Online service)
Other Objects (12)
![Diagnostic efficacy of [99mTc]Tc-PSMA SPECT/CT for prostate cancer: a meta-analysis](/assets/placeholder/searchResultMediaUnknown.png)
Diagnostic efficacy of [99mTc]Tc-PSMA SPECT/CT for prostate cancer: a meta-analysis
Tc-99m-PSMA-SPECT/CT Is Superior to Tc-99m-MDP-SPECT/CT in the Staging of Prostatic Cancer with Osseous Metastases after External Beam Radiotherapy
![Erythrozytenmarkierung mit 99mTc [Tc]](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Erythrozytenmarkierung mit 99mTc [Tc]
The Theranostic Optimization of PSMA-GCK01 Does Not Compromise the Imaging Characteristics of [99mTc]Tc-PSMA-GCK01 Compared to Dedicated Diagnostic [99mTc]Tc-EDDA/HYNIC-iPSMA in Prostate Cancer
Real world experience with [99mTc]Tc-HYNIC-iPSMA SPECT prostate cancer detection: interim results from the global NOBLE registry
Head-to-head comparison of 99mTc-PSMA and 99mTc-MDP SPECT/CT in diagnosing prostate cancer bone metastasis: a prospective, comparative imaging trial
Automated synthesis and quality control of [99mTc]Tc-PSMA for radioguided surgery (in a [68Ga]Ga-PSMA workflow)
Plasmaclearance von 99mTc-Methylendiphosphonat [Neunundneunzig-m-Tc-Methylendiphosphonat], 99mTc-Tripolyphosphat [Neunundneunzig-m-Tc-Tripolyphosphat] und 99mTc-Tetrapolyphosphat [Neunundneunzig-m-Tc-Tetrapolyphosphat] in Beziehung zur Plasmaproteinbindung
Quantitative 99mTc-DPD-SPECT/CT assessment of cardiac amyloidosis
Optimization of SPECT/CT imaging protocols for quantitative and qualitative 99mTc SPECT
Tc-99m-DMPE/Dimethylphosphinoethan
Biotinmarkierung mit Tc-99m
Diagnostic efficacy of [99mTc]Tc-PSMA SPECT/CT for prostate cancer: a meta-analysis
Tc-99m-PSMA-SPECT/CT Is Superior to Tc-99m-MDP-SPECT/CT in the Staging of Prostatic Cancer with Osseous Metastases after External Beam Radiotherapy
Erythrozytenmarkierung mit 99mTc [Tc]
The Theranostic Optimization of PSMA-GCK01 Does Not Compromise the Imaging Characteristics of [99mTc]Tc-PSMA-GCK01 Compared to Dedicated Diagnostic [99mTc]Tc-EDDA/HYNIC-iPSMA in Prostate Cancer
Real world experience with [99mTc]Tc-HYNIC-iPSMA SPECT prostate cancer detection: interim results from the global NOBLE registry
Head-to-head comparison of 99mTc-PSMA and 99mTc-MDP SPECT/CT in diagnosing prostate cancer bone metastasis: a prospective, comparative imaging trial
Automated synthesis and quality control of [99mTc]Tc-PSMA for radioguided surgery (in a [68Ga]Ga-PSMA workflow)
Plasmaclearance von 99mTc-Methylendiphosphonat [Neunundneunzig-m-Tc-Methylendiphosphonat], 99mTc-Tripolyphosphat [Neunundneunzig-m-Tc-Tripolyphosphat] und 99mTc-Tetrapolyphosphat [Neunundneunzig-m-Tc-Tetrapolyphosphat] in Beziehung zur Plasmaproteinbindung
Quantitative 99mTc-DPD-SPECT/CT assessment of cardiac amyloidosis
Optimization of SPECT/CT imaging protocols for quantitative and qualitative 99mTc SPECT
Tc-99m-DMPE/Dimethylphosphinoethan
Biotinmarkierung mit Tc-99m
Diagnostic efficacy of [99mTc]Tc-PSMA SPECT/CT for prostate cancer: a meta-analysis
Tc-99m-PSMA-SPECT/CT Is Superior to Tc-99m-MDP-SPECT/CT in the Staging of Prostatic Cancer with Osseous Metastases after External Beam Radiotherapy
Erythrozytenmarkierung mit 99mTc [Tc]
The Theranostic Optimization of PSMA-GCK01 Does Not Compromise the Imaging Characteristics of [99mTc]Tc-PSMA-GCK01 Compared to Dedicated Diagnostic [99mTc]Tc-EDDA/HYNIC-iPSMA in Prostate Cancer
Real world experience with [99mTc]Tc-HYNIC-iPSMA SPECT prostate cancer detection: interim results from the global NOBLE registry
Head-to-head comparison of 99mTc-PSMA and 99mTc-MDP SPECT/CT in diagnosing prostate cancer bone metastasis: a prospective, comparative imaging trial
Automated synthesis and quality control of [99mTc]Tc-PSMA for radioguided surgery (in a [68Ga]Ga-PSMA workflow)
Plasmaclearance von 99mTc-Methylendiphosphonat [Neunundneunzig-m-Tc-Methylendiphosphonat], 99mTc-Tripolyphosphat [Neunundneunzig-m-Tc-Tripolyphosphat] und 99mTc-Tetrapolyphosphat [Neunundneunzig-m-Tc-Tetrapolyphosphat] in Beziehung zur Plasmaproteinbindung
Quantitative 99mTc-DPD-SPECT/CT assessment of cardiac amyloidosis
Optimization of SPECT/CT imaging protocols for quantitative and qualitative 99mTc SPECT
Tc-99m-DMPE/Dimethylphosphinoethan